Transmission in the guinea pig model

Current Topics in Microbiology and Immunology

Volumn 385, Issue , 2014, Pages 157-183

  Lowen, Anice C ^a   Bouvier, Nicole M ^b   Steel, John ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HA PROTEIN; IMMUNOGLOBULIN A; LECTIN; OSELTAMIVIR; PB2 PROTEIN; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL RESISTANCE; ARTICLE; AVIAN INFLUENZA VIRUS; DISEASE MODEL; ENVIRONMENTAL FACTOR; GUINEA PIG; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; M GENE; NONHUMAN; NS GENE; PA GENE; PROTEIN LOCALIZATION; SWINE INFLUENZA VIRUS; VIROGENESIS; VIRUS ATTACHMENT; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS TRANSMISSION; ANIMAL; GENETICS; INFLUENZA VIRUS A; METABOLISM; MOUSE; PHYSIOLOGY; TRANSMISSION; VIROLOGY;

ANIMALIA; CAVIA; MAMMALIA; MUS; MUSTELA; ORTHOMYXOVIRIDAE;

ANIMALS; DISEASE MODELS, ANIMAL; GUINEA PIGS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; VIRAL PROTEINS;

EID: 84921723529     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82_2014_390     Document Type: Article

References (94)

1. Abed Y, Pizzorno A, Bouhy X, Boivin G (2011) Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses. PLoS Pathog 7:e1002431. doi:10.1371/journal.ppat.1002431
2. Alford RH, Kasel JA, Gerone PJ, Knight V (1966) Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 122:800–804
3. Azoulay-Dupuis E, Lambre CR, Soler P, Moreau J, Thibon M (1984) Lung alterationsinguinea-pigs infected with influenza virus. J Comp Pathol 94:273–283. doi:10.1016/0021-9975(84)90046-X
4. Barman S, Krylov PS, Fabrizio TP et al (2012) Pathogenicity and transmissibility of North American triple reassortant swine influenza A viruses in ferrets. PLoS Pathog 8:e1002791. doi:10.1371/journal.ppat.1002791, PPATHOGENS-D-12-00034
5. Barnett JM, Cadman A, Burrell FM, Madar SH, Lewis AP, Tisdale M, Bethell R (1999) In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir. Virology 265:286–295. doi:10.1006/viro.1999.0058
6. Baz M, Abed Y, Boivin G (2007) Characterization of drug-resistant recombinant influenza A/ H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res 74:159–162. doi:10.1016/j.antiviral.2006.10.012
7. Belser JA, Gustin KM, Maines TR, Blau DM, Zaki SR, Katz JM, Tumpey TM (2011) Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic. J Virol 85:1563–1572. doi:10.1128/JVI.02231-10
8. Belser JA, Gustin KM, Pearce MB et al (2013) Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501:556–559. doi:10.1038/nature12391
9. Bouvier NM, Lowen AC, Palese P (2008) Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J Virol. 82:10052–10058. doi:10.1128/JVI.01226-08
10. Bouvier NM, Rahmat S, Pica N (2012) Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase. J Virol 86:7268–7279. doi:10.1128/JVI.07242-12
11. Carr J, Ives J, Kelly L et al (2002) Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res 54:79–88
12. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ (2008) Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167:775–785. doi:10.1093/aje/kwm375
13. Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM Jr (2012) The global spread of drug-resistant influenza. J R Soc Interface R Soc 9:648–656. doi:10.1098/rsif.2011.0427
14. Chou YY, Albrecht RA, Pica N et al (2011) The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol 85:11235–11241. doi:10.1128/JVI.05794-11
15. Chutinimitkul S, Herfst S, Steel J et al (2010) Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 84:11802–11813. doi:10.1128/JVI.01136-10
16. de Jong MD, Simmons CP, Thanh TT et al (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12:1203–1207. doi:10.1038/nm1477
17. de Jong MD, Tran TT, Truong HK et al (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl j Med 353:2667–2672. doi:10.1056/NEJMoa054512
18. de Wit E, Munster VJ, van Riel D et al (2010) Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol 84:1597–1606. doi:10.1128/JVI.01783-09
19. Gabbard JD, Dlugolenski D, Van Riel D et al (2013) Novel H7N9 influenza virus shows low infectious dose, high growth and efficient contact transmission in the guinea pig model. J Virol. doi:10.1128/JVI.02959-13
20. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J (2005) The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A 102:18590–18595. doi:10.1073/pnas.0507415102
21. Gao HN, Lu HZ, Cao B et al (2013) Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 368:2277–2285. doi:10.1056/NEJMoa1305584
22. Gao Y, Zhang Y, Shinya K et al (2009) Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 5:e1000709. doi:10.1371/journal.ppat.1000709
23. Govorkova EA (2012) Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses. Influenza Other Respir Viruses 7:50–57
24. Gubareva LV, Bethell R, Hart GJ, Murti KG, Penn CR, Webster RG (1996) Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J Virol 70:1818–1827
25. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG (2001) Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis 183:523–531. doi:10.1086/318537
26. Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG (1998) Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 178:1257–1262
27. Gubareva LV, Robinson MJ, Bethell RC, Webster RG (1997) Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J Virol 71:3385–3390
28. Gustin KM, Belser JA, Wadford DA, Pearce MB, Katz JM, Tumpey TM, Maines TR (2011) Influenza virus aerosol exposure and analytical system for ferrets. Proc Natl Acad Sci U S A 108:8432–8437. doi:10.1073/pnas.1100768108
29. Hai R, Schmolke M, Leyva-Grado VH et al (2013) Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nature Commun 4:2854. doi:10.1038/ncomms3854
30. Herlocher ML, Carr J, Ives J, Elias S, Truscon R, Roberts N, Monto AS (2002) Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Res 54:99–111
31. Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, Monto AS (2004) Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 190:1627–1630. doi:10.1086/424572
32. Hien TT, de Jong M, Farrar J (2004) Avian influenza–a challenge to global health care structures. N Engl J Med 351:2363–2365. doi:10.1056/NEJMp048267
33. Horisberger MA, de Staritzky K (1987) A recombinant human interferon-alpha B/D hybrid with a broad host-range. J Gen Virol 68(Pt 3):945–948
34. Houser KV, Pearce MB, Katz JM, Tumpey TM (2013) Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. J Virol 87:13480–13489. doi:10.1128/JVI.02434-13
35. Ince WL, Gueye-Mbaye A, Bennink JR, Yewdell JW (2013) Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host. J Virol 87:4330–4338. doi:10.1128/JVI.02749-12
36. Ives JA, Carr JA, Mendel DB et al (2002) The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55:307–317
37. Kaminski MM, Ohnemus A, Staeheli P, Rubbenstroth D (2013) Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model. J Virol 87:1912–1915. doi:10.1128/JVI.02507-12
38. Kim JI, Lee I, Park S et al (2013) Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. J Virol 87:7539–7549. doi:10.1128/JVI.00373-13
39. Kiso M, Mitamura K, Sakai-Tagawa Y et al (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364:759–765. doi:10.1016/S0140-6736(04)16934-1
40. Kugel D, Kochs G, Obojes K et al (2009) Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol 83:3843–3851. doi:10.1128/JVI.02453-08
41. Kwon YK, Lipatov AS, Swayne DE (2009) Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus. Vet Pathol 46:138–141. doi:10.1354/vp.46-1-138
42. Lakdawala SS, Lamirande EW, Jr Suguitan AL et al (2011) Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog 7:e1002443. doi: 10.1371/journal.ppat.1002443, PPATHOGENS-D-11-01769
43. Leyva-Grado VH, Mubareka S, Krammer F, Cardenas WB, Palese P (2012) Influenza virus infection in guinea pigs raised as livestock, Ecuador. Emerg Infect Dis 18:1135–1138. doi:10.3201/eid1807.111930
44. Lowen AC, Mubareka S, Steel J, Palese P (2007) Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3:1470–1476. doi:07-PLPA-RA-0426, doi:10.1371/journal.ppat.0030151
45. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P (2006) The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A 103:9988–9992. doi:10.1073/pnas.0604157103
46. Lowen AC, Steel J, Mubareka S, Carnero E, Garcia-Sastre A, Palese P (2009) Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol 83:2803–2818. doi:10.1128/JVI.02424-08
47. Lowen AC, Steel J, Mubareka S, Palese P (2008) High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J Virol 82:5650–5652. doi:10.1128/JVI.00325-08
48. Lv J, Wei B, Yang Y et al (2012) Experimental transmission in guinea pigs of H9N2 avian influenza viruses from indoor air of chicken houses. Virus Res 170:102–108. doi:10.1016/j.virusres.2012.09.003, S0168-1702(12)00321-8
49. Ma W, Liu Q, Bawa B et al (2012) The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs. J Gen Virol 93:1261–1268. doi:10.1099/vir.0.040535-0
50. Maines TR, Chen LM, Matsuoka Y et al (2006) Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A 103:12121–12126. doi:10.1073/pnas.0605134103
51. Maines TR, Lu XH, Erb SM et al (2005) Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 79:11788–11800. doi:10.1128/JVI.79.18.11788-11800.2005
52. McKimm-Breschkin JL, Sahasrabudhe A, Blick TJ et al (1998) Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J Virol 72:2456–2462
53. Mehle A, Doudna JA (2009) Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci U S A 106:21312–21316. doi:10.1073/pnas.0911915106
54. Mubareka S, Lowen AC, Steel J, Coates AL, Garcia-Sastre A, Palese P (2009) Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 199:858–865
55. Nicholls JM, Bourne AJ, Chen H, Guan Y, Peiris JS (2007) Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 8:73. doi:10.1186/1465-9921-8-73
56. Phair JP, Kauffman CA, Jennings R, Potter CW (1979) Influenza virus infection of the guinea pig: immune response and resistance. Med Microbiol Immunol 165:241–254
57. Pica N, Chou YY, Bouvier NM, Palese P (2012) Transmission of influenza B viruses in the guinea pig. J Virol 86:4279–4287. doi:10.1128/JVI.06645-11
58. Richard M, Schrauwen EJ, de Graaf M et al (2013) Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501:560–563. doi:10.1038/nature12476
59. Schaffer FL, Soergel ME, Straube DC (1976) Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids. Arch Virol 51:263–273
60. Seibert CW, Kaminski M, Philipp J et al (2010) Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol 84:11219–11226. doi:10.1128/JVI.01424-10
61. Seibert CW, Rahmat S, Krause JC et al (2013) Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs. J Virol 87:7793–7804. doi:10.1128/JVI.00979-13
62. Seladi-Schulman J, Steel J, Lowen AC (2013) Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo. J Virol 87:13343–13353. doi:10.1128/JVI.02004-13
63. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y (2006) Avian flu: influenza virus receptors in the human airway. Nature 440:435–436. doi:10.1038/440435a
64. Shinya K, Gao Y, Cilloniz C et al (2012) Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. J Virol 86:6055–6066. doi:10.1128/JVI.00365-12
65. Siegers JY, Short KR, Leijten LME et al (In Press) Novel avian-origin influenza A (H7N9) virus attachment to the mammalian respiratory tract. J Virol
66. Smith GJ, Vijaykrishna D, Bahl J et al (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125. doi:10.1038/nature08182
67. Steel J, Lowen AC, Mubareka S, Palese P (2009) Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 5:e1000252. doi:10.1371/journal.ppat.1000252
68. Steel J, Palese P, Lowen AC (2011) Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J Virol 85:1400–1402. doi:10.1128/JVI.02186-10
69. Steel J, Staeheli P, Mubareka S, Garcia-Sastre A, Palese P, Lowen AC (2010) Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol 84:21–26. doi:10.1128/JVI.01732-09
70. Subbarao EK, London W, Murphy BR (1993) A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67:1761–1764
71. Sun Y, Bi Y, Pu J et al (2010) Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses. PLoS One 5:e15537. doi:10.1371/journal.pone.0015537
72. Tai CY, Escarpe PA, Sidwell RW et al (1998) Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrobial agents and chemotherapy 42:3234–3241
73. Tang X, Chong KT (2009) Histopathology and growth kinetics of influenza viruses (H1N1 and H3N2) in the upper and lower airways of guinea pigs. J Gen Virol 90:386–391. doi:10.1099/vir.0.007054-0
74. Treanor JJ (2010) Influenza viruses, including avian influenza and swine influenza. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practices of infectious diseases, 7th edn. Elsevier, Philadelphia
75. van der Laan JW, Herberts C, Lambkin-Williams R, Boyers A, Mann AJ, Oxford J (2008) Animal models in influenza vaccine testing. Expert Rev Vaccines 7:783–793. doi:10.1586/14760584.7.6.783
76. Van Hoeven N, Belser JA, Szretter KJ et al (2009a) Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol 83:2851–2861. doi:10.1128/JVI.02174-08
77. Van Hoeven N, Pappas C, Belser JA et al (2009b) Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A 106:3366–3371. doi:10.1073/pnas.0813172106
78. Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW (2013) Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respir Viruses 7:872–886. doi:10.1111/irv.12074
79. van Riel D, den Bakker MA, Leijten LM et al (2010) Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol 176:1614–1618. doi: S0002-9440(10)60476-2, doi:10.2353/ajpath.2010.090949
80. van Riel D, Leijten LM, de Graaf M et al (2013) Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans. Am J Pathol 183:1137–1143. doi: S0002-9440(13)00457-4, doi:10.1016/j.ajpath.2013.06.011
81. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T (2006) H5N1 virus attachment to lower respiratory tract. Science 312:399. doi:10.1126/science.1125548
82. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T (2007) Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171:1215–1223. doi: S0002-9440(10)62385-1, doi:10.2353/ajpath.2007.070248
83. Watanabe T, Kiso M, Fukuyama S et al (2013) Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551–555. doi:10.1038/nature12392
84. Wetherbee RE (1973) Induction of systemic delayed hypersensitivity during experimental viral infection of the respiratory tract with a myxovirus or paramyxovirus. J Immunol 111:157–163
85. World Health Organization (2009) Table 2: seasonal influenza A(H1N1) virus resistant to oseltamivir, last quarter 2008 to 31 March 2009. World Health Organization, Geneva, Switzerland
86. Xu L, Bao L, Deng W et al (2013) Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. J Infect Dis. doi:10.1093/infdis/jit474
87. Xu R, McBride R, Nycholat CM, Paulson JC, Wilson IA (2012) Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J Virol 86:982–990. doi:10.1128/JVI.06322-11
88. Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, Govorkova EA (2005) Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother 49:4075–4084. doi:10.1128/AAC.49.10.4075-4084.2005
89. Zeng H, Goldsmith CS, Maines TR et al (2013) Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures. J Virol 87:2597–2607. doi:10.1128/JVI.02885-12
90. Zhang Q, Shi J, Deng G et al (2013a) H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341:410–414. doi:10.1126/science.1240532
91. Zhang Y, Zhang Q, Gao Y et al (2012) Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J Virol 86:9666–9674. doi:10.1128/JVI.00958-12
92. Zhang Y, Zhang Q, Kong H et al (2013b) H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet. Science 340:1459–1463. doi:10.1126/science.1229455
93. Zhu H, Wang D, Kelvin DJ et al (2013) Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341:183–186. doi:10.1126/science.1239844
94. Zurcher T, Yates PJ, Daly J et al (2006) Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. J Antimicrob Chemother 58:723–732. doi:10.1093/jac/dkl321